Medical University of South Carolina, Charleston, SC; Roswell Park Cancer Institute, Buffalo, NY; Yale School of Medicine, Yale Cancer Center, New Haven, CT; University of Texas MD Anderson Cancer Center, Houston, TX; Rush University, Chicago, IL; Indiana University School of Medicine, Indianapolis, IN; and Arkansas Department of Health, Little Rock, AR.
J Oncol Pract. 2013 Sep;9(5):258-62. doi: 10.1200/JOP.2013.001025. Epub 2013 Jul 29.
Assessing tobacco use and providing cessation support is recommended by the American Society for Clinical Oncology (ASCO). The purpose of this study was to evaluate practice patterns and perceptions of tobacco use and barriers to providing cessation support for patients with cancer.
In 2012, an online survey was sent to 18,502 full ASCO members asking about their practice patterns regarding tobacco assessment, cessation support, perceptions of tobacco use, and barriers to providing cessation support for patients with cancer. Responses from 1,197 ASCO members are reported.
At initial visit, most respondents routinely ask patients about tobacco use (90%), ask patients to quit (80%), and advise patients to stop using tobacco (84%). However, only 44% routinely discuss medication options with patients, and only 39% provide cessation support. Tobacco assessments decrease at follow-up assessments. Most respondents (87%) agree or strongly agree that smoking affects cancer outcomes, and 86% believe cessation should be a standard part of clinical cancer care. However, only 29% report adequate training in tobacco cessation interventions. Inability to get patients to quit (72%) and patient resistance to treatment (74%) are dominant barriers to cessation intervention, but only 8% describe cessation as a waste of time.
Among ASCO members who responded to an online survey about their practice patterns regarding tobacco, most believe that tobacco cessation is important and frequently assess tobacco at initial visit, but few provide cessation support. Interventions are needed to increase access to tobacco cessation support for patients with cancer.
美国临床肿瘤学会(ASCO)建议评估烟草使用情况并提供戒烟支持。本研究旨在评估癌症患者的烟草使用情况及提供戒烟支持的实践模式和观念,并分析其戒烟支持的障碍。
2012 年,向 18502 名 ASCO 全体会员发送了一份在线调查,询问他们在烟草评估、戒烟支持、对烟草使用的看法以及为癌症患者提供戒烟支持方面的实践模式。报告了 1197 名 ASCO 会员的回应。
在初次就诊时,大多数受访者通常会询问患者有关烟草使用的情况(90%),建议患者戒烟(80%)并告知患者停止使用烟草(84%)。然而,只有 44%的受访者会定期与患者讨论药物选择,只有 39%的受访者提供戒烟支持。在后续评估中,烟草评估的频率会降低。大多数受访者(87%)同意或强烈同意吸烟会影响癌症的结果,86%的受访者认为戒烟应成为临床癌症护理的标准部分。然而,只有 29%的受访者报告接受过足够的烟草戒烟干预培训。使患者戒烟的能力不足(72%)和患者对治疗的抵触(74%)是戒烟干预的主要障碍,但只有 8%的受访者认为戒烟是浪费时间。
在回应有关烟草使用情况的在线调查的 ASCO 会员中,大多数人认为戒烟很重要,并在初次就诊时经常评估烟草使用情况,但很少提供戒烟支持。需要采取干预措施,为癌症患者提供更多的戒烟支持。